Literature DB >> 3767128

Ozone enhancement of platinum asthma in a primate model.

R E Biagini, W J Moorman, T R Lewis, I L Bernstein.   

Abstract

Three groups of adult male cynomolgus monkeys (Macaca fascicularis) were exposed to either 200 micrograms/m3 ammonium hexachloroplatinate [(NH4)2PtCl6], 200 micrograms (NH4)2PtCl6 concurrently with 1 ppm ozone (O3), or to 1 ppm O3 only. The animals were exposed by inhalation for 6 h per day, 5 days per week for 12 wk. The experimental design included methacholine preexposure and Na2PtCl6 bronchoprovocation challenge evaluations, Na2PtCl6 threshold skin tests, and sera for analyses of antibodies. Two weeks after the 12-wk exposures, these same indices were reevaluated. Baseline pulmonary function was not significantly affected by the exposure regimens; however, the combination of exposure to O3 and (NH4)2PtCl6 significantly reduced the concentration of platinum (Pt) salt and methacholine necessary to increase average pulmonary flow resistance (RL) 200% (EC200 RL). Ozone or Pt exposure alone had no significant effect on these parameters. Platinum and methacholine EC200 RL values were highly correlated for both Pt-exposed groups after exposure. These data indicated that combined O3 and Pt exposure significantly increased specific (Pt) and nonspecific (methacholine) bronchial hyperreactivity more often than did exposure to either O3 or the Pt salt alone. Combined O3 plus Pt exposure also significantly increases the incidence of positive Pt skin tests when compared with the other exposure groups. Similar to the human experience, radioallergosorbent testing (RAST) for Pt-specific antibodies was not as sensitive as direct skin testing in identifying allergic persons.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3767128     DOI: 10.1164/arrd.1986.134.4.719

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  12 in total

1.  Ozone differentially modulates airway responsiveness in atopic versus nonatopic guinea pigs.

Authors:  Richard B Schlesinger; Mitchell D Cohen; Terry Gordon; Christine Nadziejko; Judith T Zelikoff; Maureen Sisco; Jean F Regal; Margaret G Ménache
Journal:  Inhal Toxicol       Date:  2002-05       Impact factor: 2.724

2.  Role of occupational exposure to airway irritants in the development of asthma.

Authors:  M Antti-Poika; H Nordman; M Koskenvuo; J Kaprio; M Jalava
Journal:  Int Arch Occup Environ Health       Date:  1992       Impact factor: 3.015

Review 3.  Pollution-induced airway disease and the putative underlying mechanisms.

Authors:  C Rusznak; J L Devalia; J Wang; R J Davies
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

Review 4.  Pollution: does it cause asthma?

Authors:  M L Burr
Journal:  Arch Dis Child       Date:  1995-05       Impact factor: 3.791

Review 5.  In vivo models of occupational asthma due to low molecular weight chemicals.

Authors:  J P Hayes; A J Newman Taylor
Journal:  Occup Environ Med       Date:  1995-08       Impact factor: 4.402

6.  Asthma in children: environmental factors.

Authors:  P Cullinan; A J Taylor
Journal:  BMJ       Date:  1994-06-18

Review 7.  Genes of innate immunity and the biological response to inhaled ozone.

Authors:  Zhuowei Li; Robert M Tighe; Feifei Feng; Julie G Ledford; John W Hollingsworth
Journal:  J Biochem Mol Toxicol       Date:  2012-11-20       Impact factor: 3.642

Review 8.  Ambient ozone and pulmonary innate immunity.

Authors:  Mashael Al-Hegelan; Robert M Tighe; Christian Castillo; John W Hollingsworth
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

9.  Smoking and occupational allergy in workers in a platinum refinery.

Authors:  K M Venables; M B Dally; A J Nunn; J F Stevens; R Stephens; N Farrer; J V Hunter; M Stewart; E G Hughes; A J Newman Taylor
Journal:  BMJ       Date:  1989-10-14

10.  Smoking, atopy, and laboratory animal allergy.

Authors:  K M Venables; J L Upton; E R Hawkins; R D Tee; J L Longbottom; A J Newman Taylor
Journal:  Br J Ind Med       Date:  1988-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.